California Stem Cell Agency Wants to Weaken Financial Disclosure for Execs and Board
The $3 billion California stem cell agency, which is moving to engage the biotech industry ever more closely, is proposing a major weakening of the financial disclosure requirements for its board of directors and executives.
The move comes as the agency is also seeking to raise cash from the private sector to continue the state research effort's existenc…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.